van Haelst PL - Search Results

1

Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests.

Monnink SH, van Haelst PL, van Boven AJ, Stroes ES, Tio RA, Plokker TW, Smit AJ, Veeger NJ, Crijns HJ, van Gilst WH. Monnink SH, et al. Among authors: van gilst wh, van boven aj, van haelst pl. J Investig Med. 2002 Jan;50(1):19-24. doi: 10.2310/6650.2002.33513. J Investig Med. 2002. PMID: 11820226

2

Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris.

Asselbergs FW, Monnink SH, Veeger NJ, van Boven AJ, van Haelst PL, Jessurun GA, van Gilst WH, Tio RA. Asselbergs FW, et al. Among authors: van gilst wh, van boven aj, van haelst pl. Clin Sci (Lond). 2004 Feb;106(2):115-20. doi: 10.1042/CS20030215. Clin Sci (Lond). 2004. PMID: 12956627

3

Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia.

van Haelst PL, van Doormaal JJ, Asselbergs FW, van Roon AM, Veeger NJ, Henneman MM, Smit AJ, Tervaert JW, May JF, Gans RO. van Haelst PL, et al. Among authors: van doormaal jj, van roon am. Clin Sci (Lond). 2003 Jun;104(6):627-32. doi: 10.1042/CS20020293. Clin Sci (Lond). 2003. PMID: 12558496 Clinical Trial.

4

Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1.

van Haelst PL, Tervaert JW, van Geel PP, Veeger NJ, Gurné O, Gans RO, van Gilst WH. van Haelst PL, et al. Among authors: van gilst wh, van geel pp. Eur J Vasc Endovasc Surg. 2003 Oct;26(4):387-91. doi: 10.1016/s1078-5884(03)00084-4. Eur J Vasc Endovasc Surg. 2003. PMID: 14512000 Free article. Clinical Trial.

5

Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction.

van Haelst PL, Liem A, van Boven AJ, Veeger NJ, van Veldhuisen DJ, Tervaert JW, Gans RO, Zijlstra F. van Haelst PL, et al. Among authors: van boven aj, van veldhuisen dj. Am J Cardiol. 2003 Nov 15;92(10):1201-3. doi: 10.1016/j.amjcard.2003.07.031. Am J Cardiol. 2003. PMID: 14609597

6

Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products.

Mulder DJ, van Haelst PL, Gross S, de Leeuw K, Bijzet J, Graaff R, Gans RO, Zijlstra F, Smit AJ. Mulder DJ, et al. Among authors: van haelst pl. Atherosclerosis. 2008 Mar;197(1):217-23. doi: 10.1016/j.atherosclerosis.2007.03.027. Epub 2007 May 17. Atherosclerosis. 2008. PMID: 17499742

7

Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: prevalence and association with risk factors.

van Haelst PL, Asselbergs FW, van Doormaal JJ, Veeger NJ, May JF, Holvoet P, Gans RO, Tervaert JW. van Haelst PL, et al. Among authors: van doormaal jj. J Intern Med. 2002 Jan;251(1):29-34. doi: 10.1046/j.1365-2796.2002.00920.x. J Intern Med. 2002. PMID: 11851862 Free article.

8

Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events.

Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Mulder DJ, et al. Among authors: van haelst pl. Neth Heart J. 2009 Apr;17(4):162-8. doi: 10.1007/BF03086239. Neth Heart J. 2009. PMID: 19421362 Free PMC article.

9

No long-lasting or intermittent mast cell activation in acute coronary syndromes.

van Haelst PL, Timmer JR, Crijns HJ, Kauffman HF, Gans RO, van Doormaal JJ. van Haelst PL, et al. Among authors: van doormaal jj. Int J Cardiol. 2001 Mar;78(1):75-80. doi: 10.1016/s0167-5273(00)00475-7. Int J Cardiol. 2001. PMID: 11259815

10

Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.

Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA. Wijpkema JS, et al. Among authors: van der steege g, van haelst pl. Pharmacogenet Genomics. 2006 May;16(5):331-7. doi: 10.1097/01.fpc.0000205001.07054.fa. Pharmacogenet Genomics. 2006. PMID: 16609364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page